Nonoxynol-9 Spermicides May Need Review After Clinical Trial Results
This article was originally published in The Tan Sheet
Executive Summary
Appointment of an outside team of investigators to independently review the nonoxynol-9 data generated by the UNAIDS Phase III efficacy trial in the prevention of male-to-female HIV transmission is being urged by Columbia Laboratories.
You may also be interested in...
N-9 Data Warrants Spermicide Safety Study, WHO Report Recommends
The safety of all spermicides should be evaluated in light of recent research indicating the one-time top microbicide candidate nonoxynol-9 actually causes lesions that may facilitate transmission of HIV and other sexually transmitted infections, according to the final report of a "Technical Consultation on N-9," released June 25
N-9 Data Warrants Spermicide Safety Study, WHO Report Recommends
The safety of all spermicides should be evaluated in light of recent research indicating the one-time top microbicide candidate nonoxynol-9 actually causes lesions that may facilitate transmission of HIV and other sexually transmitted infections, according to the final report of a "Technical Consultation on N-9," released June 25
N-9 Data Warrants Spermicide Safety Study, WHO Report Recommends
The safety of all spermicides should be evaluated in light of recent research indicating the one-time top microbicide candidate nonoxynol-9 actually causes lesions that may facilitate transmission of HIV and other sexually transmitted infections, according to the final report of a "Technical Consultation on N-9," released June 25